BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2585 related articles for article (PubMed ID: 27568654)

  • 1. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; van der Kwast TH; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; van der Poel HG; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Cornford P
    Eur Urol; 2021 Feb; 79(2):243-262. PubMed ID: 33172724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
    Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
    Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Cornford P; van den Bergh RCN; Briers E; Van den Broeck T; Brunckhorst O; Darraugh J; Eberli D; De Meerleer G; De Santis M; Farolfi A; Gandaglia G; Gillessen S; Grivas N; Henry AM; Lardas M; van Leenders GJLH; Liew M; Linares Espinos E; Oldenburg J; van Oort IM; Oprea-Lager DE; Ploussard G; Roberts MJ; Rouvière O; Schoots IG; Schouten N; Smith EJ; Stranne J; Wiegel T; Willemse PM; Tilki D
    Eur Urol; 2024 Apr; ():. PubMed ID: 38614820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
    Cornford P; van den Bergh RCN; Briers E; Van den Broeck T; Cumberbatch MG; De Santis M; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Grummet J; Henry AM; der Kwast THV; Lam TB; Lardas M; Liew M; Mason MD; Moris L; Oprea-Lager DE; der Poel HGV; Rouvière O; Schoots IG; Tilki D; Wiegel T; Willemse PM; Mottet N
    Eur Urol; 2021 Feb; 79(2):263-282. PubMed ID: 33039206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F;
    Eur Urol; 2011 Jan; 59(1):61-71. PubMed ID: 21056534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease].
    Heidenreich A; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Mottet N; Schmid HP; van der Kwast T; Wiegel T; Zattoni F
    Actas Urol Esp; 2011 Oct; 35(9):501-14. PubMed ID: 21757259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-risk Prostate Cancer: Identification, Management, and Outcomes.
    Moschini M; Carroll PR; Eggener SE; Epstein JI; Graefen M; Montironi R; Parker C
    Eur Urol; 2017 Aug; 72(2):238-249. PubMed ID: 28318726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
    Tilki D; van den Bergh RCN; Briers E; Van den Broeck T; Brunckhorst O; Darraugh J; Eberli D; De Meerleer G; De Santis M; Farolfi A; Gandaglia G; Gillessen S; Grivas N; Henry AM; Lardas M; J L H van Leenders G; Liew M; Linares Espinos E; Oldenburg J; van Oort IM; Oprea-Lager DE; Ploussard G; Roberts MJ; Rouvière O; Schoots IG; Schouten N; Smith EJ; Stranne J; Wiegel T; Willemse PM; Cornford P
    Eur Urol; 2024 Apr; ():. PubMed ID: 38688773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; Van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Eur Urol; 2011 Apr; 59(4):572-83. PubMed ID: 21315502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAU guidelines on prostate cancer.
    Heidenreich A; Aus G; Bolla M; Joniau S; Matveev VB; Schmid HP; Zattoni F;
    Eur Urol; 2008 Jan; 53(1):68-80. PubMed ID: 17920184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
    Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
    Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
    Lam TBL; MacLennan S; Willemse PM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N
    Eur Urol; 2019 Dec; 76(6):790-813. PubMed ID: 31587989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EAU guidelines on prostate cancer].
    Heidenreich A; Aus G; Bolla M; Joniau S; Matveev VB; Schmid HP; Zattoni F;
    Actas Urol Esp; 2009 Feb; 33(2):113-26. PubMed ID: 19418833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
    Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
    Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
    Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
    Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 130.